explore -WSS

explore

author：focus 2025-09-02 17:51:07 - browse：9252

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Childhood cancer progress stalls for Black, Hispanic kids: Report

WSS

World's first CRISPR

UnitedHealth’s board chair also owns a personal investment firm

CEOs share strategies for surviving biotech slump

CRISPR pioneers react to Casgevy, first gene

World's first CRISPR

Why health workers in Gaza are injured or die at high rates

entertainment

explore

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

How climate

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Activists slam private health insurers over coverage restrictions

Poor hospice wound care hurts patients and families

Supreme Court strikes down use of affirmative action

Impact of Dobbs ruling felt at reproductive medicine meeting

Moonlake's readout produced a cash windfall. Risks remain

Pharmacists can make shortage drugs, but at what cost?

hotspot

PBM reforms clear House panel

U.K. considers world's first use of meningitis vaccine to address gonorrhea

First Opinion Podcast: Long Covid needs a new approach

STAT Summit: GSK CEO on pharma giant's new direction

Why medical students are struggling with mental health

David Sabatini, ex

entertainment

Wikipedia

entertainment

knowledge